long intergenic non-protein coding RNA 1983Genealiases: []
Q-omics provides the consensus-scored LINC01983 profile across patient tissues and cancer cell-line models. LINC01983 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in LGG. Among the 18 cancer types available for tumor–normal comparison, LINC01983 is differentially expressed in 8, with the highest sampling consensus in KIRC. Additionally, LINC01983 RNA expression shows 8,945 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight LGG, KIRC, and TGCT as cancer lineages where LINC01983 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01983 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01983 survival associations across molecular data types. LINC01983 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01983 RNA expression–survival associations across cancer types. High LINC01983 expression shows unfavorable associations in COAD, UVM and DLBC, but favorable associations in LGG, HNSC and ESCA. The LGG Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for LINC01983 RNA expression.
This table summarizes LINC01983 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01983. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01983 shows lower tumor expression in KIRC, KIRP, HNSC and KICH and higher tumor expression in LUAD and BRCA. The KIRC box plot shows higher LINC01983 RNA expression in normal versus tumor tissue (log2 FC = −2.567, t-test p < 0.001).
This table shows molecular features associated with LINC01983 in patient tissues and cancer cell lines. In patient samples, LINC01983 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
